HYOLEV MB (Burel Pharmaceuticals, Inc)
Welcome to the PulseAid listing for the HYOLEV MB drug offered from Burel Pharmaceuticals, Inc. This Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Burel Pharmaceuticals, Inc |
| NON-PROPRIETARY NAME: | hyoscyamine sulfate, methenamine, methylene blue, phenyl salicylate, and sodium phosphate, monobasic, monohydrate |
| SUBSTANCE NAME: | HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2015-06-26 |
| END MARKETING DATE: | 0000-00-00 |
HYOLEV MB HUMAN PRESCRIPTION DRUG Details:
| Item Description | HYOLEV MB from Burel Pharmaceuticals, Inc |
| LABELER NAME: | Burel Pharmaceuticals, Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | .12; 81; 10.8; 32.4; 40.8(mg/1; mg/1; mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2015-06-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 35573-301_094f5129-8db3-4d3b-88da-4c897355ae94 |
| PRODUCT NDC: | 35573-301 |
| APPLICATION NUMBER: | |
Other HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE Pharmaceutical Manufacturers / Labelers:
